Literature DB >> 27622993

Metabolic and hormone influences on emotion processing during menopause.

Alison Berent-Spillson1, Courtney Marsh2, Carol Persad3, John Randolph4, Jon-Kar Zubieta5, Yolanda Smith4.   

Abstract

Disturbances of emotion regulation and depressive symptoms are common during the menopause transition. Reproductive hormone levels are not directly correlated with depressive symptoms, and other factors may influence mood symptoms during menopause. In this study, we sought to determine the role of metabolic function in mood symptoms during menopause, hypothesizing an association with menopause status and long-term glucose load. We studied 54 women across three menopause transition stages (15 premenopause, 11 perimenopause, and 28 postmenopause), examining effects of age, hormones, and metabolism on mood and neural activation during emotional discrimination. We assessed participants using behavioral and functional MRI measures of negative emotion and emotion discrimination, and glycated hemoglobin A1c, to assess long-term glucose load. We found that emotionally unpleasant images activated emotion regulation (amygdala) and cognitive association brain regions (prefrontal cortex, posterior cingulate, temporal-parietal-occipital (TPO) junction, hippocampus). Cognitive association region activity increased with menopause stage. Perimenopausal women had left TPO junction activation, and postmenopausal women had prefrontal cortex, posterior cingulate, and TPO junction activation. Negative affect was associated with decreased amygdala activation, while depression symptoms and negative mood were associated with increased TPO junction activation. Hemoglobin A1c was associated with negative interpretation bias of neutral images and cognitive region recruitment during emotion discrimination. FSH levels, indicating menopause stage, were associated with negative mood. Age was not associated with any behavioral measures or activation patterns during the emotion task. Our results suggest that an interaction between metabolic and hormonal factors may influence emotion regulation, leading to increased risk for depression during menopause.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Emotion regulation; Menopause; Metabolism; Perimenopause; fMRI

Mesh:

Substances:

Year:  2016        PMID: 27622993      PMCID: PMC5272799          DOI: 10.1016/j.psyneuen.2016.08.026

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  41 in total

1.  Adult and geriatric normative data and validation of the profile of mood states.

Authors:  D L Nyenhuis; C Yamamoto; T Luchetta; A Terrien; A Parmentier
Journal:  J Clin Psychol       Date:  1999-01

2.  Hormone-related factors and post-menopausal onset depression: results from KNHANES (2010-2012).

Authors:  Sun Jae Jung; Aesun Shin; Daehee Kang
Journal:  J Affect Disord       Date:  2015-01-14       Impact factor: 4.839

Review 3.  Insulin resistance in depressive disorders and Alzheimer's disease: revisiting the missing link hypothesis.

Authors:  Natalie L Rasgon; Heather A Kenna
Journal:  Neurobiol Aging       Date:  2005-10-11       Impact factor: 4.673

Review 4.  The emergence of the metabolic syndrome with menopause.

Authors:  Molly C Carr
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

5.  Blood glucose levels and cortical thinning in cognitively normal, middle-aged adults.

Authors:  Alexandra M V Wennberg; Adam P Spira; Corinne Pettigrew; Anja Soldan; Vadim Zipunnikov; George W Rebok; Allen D Roses; Michael W Lutz; Michael M Miller; Madhav Thambisetty; Marilyn S Albert
Journal:  J Neurol Sci       Date:  2016-04-14       Impact factor: 3.181

6.  Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.

Authors:  L R Baxter; M E Phelps; J C Mazziotta; J M Schwartz; R H Gerner; C E Selin; R M Sumida
Journal:  Arch Gen Psychiatry       Date:  1985-05

7.  Functional neuroimaging of emotional processing in women with polycystic ovary syndrome: a case-control pilot study.

Authors:  Courtney A Marsh; Alison Berent-Spillson; Tiffany Love; Carol C Persad; Rodica Pop-Busui; Jon-Kar Zubieta; Yolanda R Smith
Journal:  Fertil Steril       Date:  2013-04-01       Impact factor: 7.329

8.  Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition.

Authors:  Jennifer L Gordon; David R Rubinow; Tory A Eisenlohr-Moul; Jane Leserman; Susan S Girdler
Journal:  Menopause       Date:  2016-03       Impact factor: 2.953

9.  Anatomo-functional study of the temporo-parieto-occipital region: dissection, tractographic and brain mapping evidence from a neurosurgical perspective.

Authors:  Alessandro De Benedictis; Hugues Duffau; Beatrice Paradiso; Enrico Grandi; Sergio Balbi; Enrico Granieri; Enzo Colarusso; Franco Chioffi; Carlo Efisio Marras; Silvio Sarubbo
Journal:  J Anat       Date:  2014-06-30       Impact factor: 2.610

Review 10.  Insulin, aging, and the brain: mechanisms and implications.

Authors:  Abimbola A Akintola; Diana van Heemst
Journal:  Front Endocrinol (Lausanne)       Date:  2015-02-06       Impact factor: 5.555

View more
  7 in total

1.  Ojayeonjonghwan, an oriental medicine composed of five seeds, protects against vasomotor and neurological disorders in estrogen-deficient rats.

Authors:  Byoung-Seob Ko; Jin Ah Ryuk; Joo Tae Hwang; Ting Zhang; Xuangao Wu; Sunmin Park
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-05

Review 2.  Ovarian steroid hormones: A long overlooked but critical contributor to brain aging and Alzheimer's disease.

Authors:  Steven Jett; Eva Schelbaum; Grace Jang; Camila Boneu Yepez; Jonathan P Dyke; Silky Pahlajani; Roberta Diaz Brinton; Lisa Mosconi
Journal:  Front Aging Neurosci       Date:  2022-07-19       Impact factor: 5.702

Review 3.  Steroid Hormone Sensitivity in Reproductive Mood Disorders: On the Role of the GABAA Receptor Complex and Stress During Hormonal Transitions.

Authors:  Sophie Schweizer-Schubert; Jennifer L Gordon; Tory A Eisenlohr-Moul; Samantha Meltzer-Brody; Katja M Schmalenberger; Radoslaw Slopien; Anna-Lena Zietlow; Ulrike Ehlert; Beate Ditzen
Journal:  Front Med (Lausanne)       Date:  2021-01-18

4.  Differential effects of estradiol on neural and emotional stress response in postmenopausal women with remitted Major Depressive Disorder.

Authors:  Kimberly M Albert; Brian D Boyd; Warren D Taylor; Paul A Newhouse
Journal:  J Affect Disord       Date:  2021-06-25       Impact factor: 6.533

5.  Prediction of risk of depressive symptoms in menopausal women based on hot flash and sweating symptoms: a multicentre study.

Authors:  Yanwei Zheng; Yibei Zhou; Jiangshan Hu; Jieping Zhu; Qi Hua; Minfang Tao
Journal:  Clin Interv Aging       Date:  2017-11-23       Impact factor: 4.458

6.  FSHR ablation induces depression-like behaviors.

Authors:  Wen-Kai Bi; Shan-Shan Shao; Zhi-Wei Li; Yong-Wei Ruan; Si-Si Luan; Zhen-Hua Dong; Jing Wang; Shan-Shan Wu; Tian Guo; Shi-Zhan Ma; Ling Gao; Jia-Jun Zhao; Zhao He
Journal:  Acta Pharmacol Sin       Date:  2020-03-18       Impact factor: 6.150

Review 7.  The many menopauses: searching the cognitive research literature for menopause types.

Authors:  Hannaford Edwards; Annie Duchesne; April S Au; Gillian Einstein
Journal:  Menopause       Date:  2019-01       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.